{
 "drug": "Insulin Glargine Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/24/2025",
 "dayN": 305,
 "cat": "Endocrinology/Metabolism",
 "companies": [
  "Eli Lilly and Co."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/24/2025",
   "update_type": "New",
   "initial_posting_date": "10/24/2025",
   "package_ndc": "0002-8214-05",
   "generic_name": "Insulin Glargine Injection",
   "contact_info": "800-545-5979",
   "related_info": "A business decision was made to discontinue manufacture of the drug.",
   "update_date": "10/24/2025",
   "therapeutic_category": [
    "Endocrinology/Metabolism"
   ],
   "dosage_form": "Injection",
   "presentation": "Basaglar, Injection, U-100 Tempo Pen (NDC 0002-8214-05)",
   "company_name": "Eli Lilly and Co.",
   "status": "To Be Discontinued"
  }
 ]
}